Moderna on Vaccines, Therapeutics, and the Future of Kids’ Health

Dr. Wendy Sohn, executive director at Moderna and pediatrician, joins us to unpack urgent updates on COVID vaccine access for children, upcoming FDA decisions, and what Moderna is doing to protect kids in the seasons ahead. We also explore the company’s broader pipeline—from a game-changing CMV vaccine to breakthrough therapies for rare childhood diseases. A must-listen for parents, advocates, and anyone tracking the future of pediatric health.

About Dr. Wendy Sohn

Wendy Sohn is an accomplished executive with extensive experience in the biopharmaceutical industry, currently serving as the Executive Director at Moderna. With a proven track record of driving innovation and strategic growth, Wendy is a visionary leader at the forefront of vaccine development and global health initiatives. Her expertise lies in R&D and strategic partnering, where she has successfully led cross-functional teams to advance cutting-edge vaccine technologies.

Throughout her career, Wendy has been instrumental in shaping the future of the global vaccine industry, leveraging her deep understanding of market trends and regulatory landscapes to bring life-saving vaccines to market. Her passion for improving public health outcomes and dedication to scientific excellence have earned her recognition as a key opinion leader in the field.